nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A collaborative study to establish the 1st WHO International Standard for Epstein–Barr virus for nucleic acid amplification techniques
|
Fryer, Jacqueline F. |
|
2016 |
44 |
5 |
p. 423-433 11 p. |
artikel |
2 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2016 |
44 |
5 |
p. IFC- 1 p. |
artikel |
3 |
Collagen-graft mixed cellulose esters membrane maintains undifferentiated morphology and markers of potential pluripotency in feeder-free culture of induced pluripotent stem cells
|
Lotfalah Moradi, Sadegh |
|
2016 |
44 |
5 |
p. 387-393 7 p. |
artikel |
4 |
CT-P13 (Inflectra™, Remsima™) monitoring in patients with inflammatory bowel disease
|
Schulze, Kornelius |
|
2016 |
44 |
5 |
p. 463-466 4 p. |
artikel |
5 |
Determination of critical quality attributes for monoclonal antibodies using quality by design principles
|
Alt, Nadja |
|
2016 |
44 |
5 |
p. 291-305 15 p. |
artikel |
6 |
Endotoxin recovery using limulus amebocyte lysate (LAL) assay
|
Bolden, Jay S. |
|
2016 |
44 |
5 |
p. 434-440 7 p. |
artikel |
7 |
Enhanced efficacy of DNA vaccination against botulinum neurotoxin serotype A by co-administration of plasmids encoding DC-stimulating Flt3L and MIP-3α cytokines
|
Xu, Qing |
|
2016 |
44 |
5 |
p. 441-447 7 p. |
artikel |
8 |
Establishing a control system using QbD principles
|
Kepert, J. Felix |
|
2016 |
44 |
5 |
p. 319-331 13 p. |
artikel |
9 |
Establishment of an equine tetanus antitoxin reference standard for veterinary use in Japan
|
Hirano, Fumiya |
|
2016 |
44 |
5 |
p. 374-377 4 p. |
artikel |
10 |
Establishment of replacement International Standard 13/132 for human antibodies to Toxoplasma gondii
|
Rijpkema, Sjoerd |
|
2016 |
44 |
5 |
p. 448-455 8 p. |
artikel |
11 |
Foreword: Quality by Design for monoclonal antibodies: Description of an integrated system
|
Kelley, Brian |
|
2016 |
44 |
5 |
p. 281- 1 p. |
artikel |
12 |
Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives
|
Yunoki, Mikihiro |
|
2016 |
44 |
5 |
p. 403-411 9 p. |
artikel |
13 |
High-risk human papilloma virus genotypes in cervical carcinoma of Serbian women: Distribution and association with pathohistological findings
|
Stamenković, Miodrag |
|
2016 |
44 |
5 |
p. 412-416 5 p. |
artikel |
14 |
Integration of QbD risk assessment tools and overall risk management
|
Kelley, Brian |
|
2016 |
44 |
5 |
p. 341-351 11 p. |
artikel |
15 |
Intra-family differences in efficacy of inactivation of small, non-enveloped viruses
|
Nims, Raymond W. |
|
2016 |
44 |
5 |
p. 456-462 7 p. |
artikel |
16 |
Introduction to the application of QbD principles for the development of monoclonal antibodies
|
Finkler, Christof |
|
2016 |
44 |
5 |
p. 282-290 9 p. |
artikel |
17 |
Masking of endotoxin in surfactant samples: Effects on Limulus-based detection systems
|
Reich, Johannes |
|
2016 |
44 |
5 |
p. 417-422 6 p. |
artikel |
18 |
Probe-free and sensitive detection of diarrhea-causing pathogens using RT-PCR combined high resolution melting analysis
|
Wang, Hai-Bo |
|
2016 |
44 |
5 |
p. 360-366 7 p. |
artikel |
19 |
Process characterization and Design Space definition
|
Hakemeyer, Christian |
|
2016 |
44 |
5 |
p. 306-318 13 p. |
artikel |
20 |
Production of recombinant non-structural protein-3 hydrophobic domain deletion (NS3ΔHD) protein of bluetongue virus from prokaryotic expression system as an efficient diagnostic reagent
|
Mohanty, Nihar Nalini |
|
2016 |
44 |
5 |
p. 352-359 8 p. |
artikel |
21 |
Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection
|
Banadkoki, Abbas Zare |
|
2016 |
44 |
5 |
p. 367-373 7 p. |
artikel |
22 |
QbD implementation and Post Approval Lifecycle Management (PALM)
|
Ohage, Ettore |
|
2016 |
44 |
5 |
p. 332-340 9 p. |
artikel |
23 |
Recombinant production and characterization of human anti-influenza virus monoclonal antibodies identified from hybridomas fused with human lymphocytes
|
Misaki, Ryo |
|
2016 |
44 |
5 |
p. 394-402 9 p. |
artikel |
24 |
Report of the International Regulatory Forum on Human Cell Therapy and Gene Therapy Products
|
Hayakawa, Takao |
|
2016 |
44 |
5 |
p. 467-479 13 p. |
artikel |
25 |
Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens
|
Asadi Karam, Mohammad Reza |
|
2016 |
44 |
5 |
p. 378-386 9 p. |
artikel |